Endoscopic biliary drainage for patients with unresectable pancreatic cancer with obstructive jaundice who are to undergo gemcitabine chemotherapy

Table 4 Adverse effects of GEM chemotherapy n (%)

	Grade
	1	2	3
Bone marrow 24 (89)
(n = 27)
Leukocytes 17 (71)	5 (21)	10 (42)	2 (8)
Hemoglobin 17 (71)	10 (42)	7 (29)
Platelets 6 (25)	3 (13)	1 (4)	2 (8)
Gastrointestinal 6 (20)
(n = 30)
Anorexia 3 (9)		1 (3)	2 (6)
Nausea 5 (15)	2 (6)	2 (6)	1 (3)

Administration of gemcitabine (GEM) was abandoned due to adverse effects in 4 patients.